Stellalife Vega Oral Care Rinse

Rinse


Stellalife, Inc.
Human Otc Drug
NDC 69685-103
Stellalife Vega Oral Care Rinse also known as Rinse is a human otc drug labeled by 'Stellalife, Inc.'. National Drug Code (NDC) number for Stellalife Vega Oral Care Rinse is 69685-103. This drug is available in dosage form of Rinse. The names of the active, medicinal ingredients in Stellalife Vega Oral Care Rinse drug includes Azadirachta Indica Bark - 1 [hp_X]/mL Calendula Officinalis Flower - 1 [hp_X]/mL Echinacea Purpurea - 1 [hp_X]/mL Plantago Major - 1 [hp_X]/mL . The currest status of Stellalife Vega Oral Care Rinse drug is Active.

Drug Information:

Drug NDC: 69685-103
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Stellalife Vega Oral Care Rinse
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Rinse
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Stellalife, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Rinse
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:AZADIRACHTA INDICA BARK - 1 [hp_X]/mL
CALENDULA OFFICINALIS FLOWER - 1 [hp_X]/mL
ECHINACEA PURPUREA - 1 [hp_X]/mL
PLANTAGO MAJOR - 1 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:DENTAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 08 Feb, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 06 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:StellaLife, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
UNII:G580B439YI
P0M7O4Y7YD
QI7G114Y98
W2469WNO6U
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
69685-103-161 BOTTLE, PLASTIC in 1 BOX (69685-103-16) / 473 mL in 1 BOTTLE, PLASTIC08 Feb, 2019N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Rinse keep out of childrem recovery kit reach out of children gel keep out of children

Recovery kit, gel, rinse spray gel purpose recovery kit purpose

Product Elements:

Stellalife vega oral care rinse rinse mentha piperita leaf citric acid monohydrate glycerin peppermint oil polysorbate 20 potassium sorbate xylitol water azadirachta indica bark azadirachta indica bark calendula officinalis flower calendula officinalis flower allantoin echinacea purpurea echinacea purpurea plantago major plantago major propolis wax

Indications and Usage:

Recovery kit, gel, spray, rinse indications and usage gel usage recovery kit usage spray usage

Warnings:

Recovery kit, gel, spray, rinse warning section spray warning recovery kit rinse gel

Dosage and Administration:

Recovery kit, gel, rinse, spay spray dosage dosage and administration gel dosage rinse lable

Package Label Principal Display Panel:

Recovery kit principal display panel recovery kit pdp

Gel principle display panel gel ​gel principle display panel

Rinse gel principle display panel rinse ​​gel principle display panel

Spray rinse gel principle display panel spray principle display panel


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.